Spiral Therapeutics, Inc.

About Spiral Therapeutics, Inc.

Spiral Therapeutics is a clinical-stage company focused on advancing a therapeutic pipeline for balance disorders and hearing loss. Their mission is to improve lives by protecting hearing through innovative drug delivery solutions inspired by ophthalmology, delivering the right drugs to the right place for the right duration.

Products & Services

SPT-2101:A sustained-release steroid formulation (6% dexamethasone) for the treatment of Ménière's disease, delivered using the Minimally Invasive Cochlear System (MICS™) platform. It has completed a Phase 1b/2a clinical trial showing superior vertigo management.

MICS™ (Minimally-Invasive Cochlear System):A delivery platform designed to administer a wide range of drugs to the ear with high precision and long duration, suitable for clinic-friendly approaches. It supports formulations for anti-inflammatory, otoprotective, and neuroprotective treatments for balance disorders and hearing loss.

Specialties

Balance disorders Hearing loss treatment Drug delivery to the inner ear Minimally invasive cochlear systems Sustained-release formulations

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 8250000 MR: - FA: $8.25M FAN: 8250000	D: 2023-01-09 FD: 2023-01-09	4 investors

Equity Financing Latest

2023-01-09

$8.2M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Hugo Peris

FOUNDER & CEO

LinkedIn (Pro only)

C

Charles Limb

Professor of Otolaryngology - Head and Neck Surgery

J

Jeffrey Sharon

SVP Clinical Science

LinkedIn (Pro only)

K

Kyle Peterson

CHIEF FINANCIAL OFFICER

E

Eugene de Juan

Professor

B

Benson Jung

DIRECTOR R&D

View 11 more team members with Pro

Unlock Full Team Directory

Recent News